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The detection and management of potential donor-
derived infections is challenging, in part due to the
complexity of communications between diverse labs,
organ procurement organizations (OPOs), and recipi-
ent transplant centers. We sought to determine if
communication delays or errors occur in the reporting
and management of donor-derived infections and if
these are associated with preventable adverse events
in recipients. All reported potential donor-derived
transmission events reviewed by the Organ Procure-
ment and Transplantation Network Ad Hoc Disease
Transmission Advisory Committee from January 2008
to June 2010 were evaluated for communication gaps
between the donor center, OPOand transplant centers.
The impact on recipient outcomes was then deter-
mined. Fifty-six infection events (IEs; involving 168
recipients) were evaluated. Eighteen IEs (48 recipients)
were associated with communication gaps, of which
12 resulted in adverse effects in 69% of recipients
(20/29), including six deaths. When IEs and test results
were reported without delay, appropriate interven-
tions were taken, subsequently minimizing or averting
recipient infection (23 IEs, 72 recipients). Communica-
tion gaps in reported IEs are frequent, occur atmultiple
levels in the communication process, and contribute to
adverse outcomes among affected transplant recipi-
ents. Conversely, effective communication minimized
or averted infection in transplant recipients.
Abbreviations: DTAC, Ad Hoc Disease Transmission
Advisory Committee; ESBL, extended spectrum beta-
lactamase; GNR, Gram-negative rods; IE, infection
event; IWDT, intervention without documented trans-
mission; MRSA, methicillin resistant Staphylococcus
aureus; OPO, organ procurement organization; OPTN,
Organ Procurement and Transplantation Network;
R, recipient; UNOS,UnitedNetwork for Organ Sharing;
VRE, vancomycin resistant Enterococcus
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Introduction
As the organ donor shortage becomes magnified by
increasing numbers of individuals with organ failure on
transplant waiting lists, the increased demand results in the
routine use of organs from deceased donors with known or
increased risk for infection. Organ donor screening for
infections is currently based on donor history, physical
assessment and laboratory testing (1,2). However, to
maximize organ utilization and minimize time delays to
optimize allograft function, organs may occasionally be
transplanted before behavioral risk factors and/or confirma-
tory testing of initial laboratory screening tests are fully
known based upon a recipient’s critical need and life
expectancy without immediate transplant. Additionally,
there are areas of the United States that do not have
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access to timely nucleic acid testing to screen for
transmissible viruses. Although transplant transmitted
infections are uncommon, they continue to occur due to
recognized challenges in detecting these infections and the
use of imperfect screening tools (3–5). Even if a donor
transmitted infection is suspected in a transplant recipient,
clinicians may be unaware of how to obtain and/or report
relevant donor/recipient information (6).
Organ Procurement and Transplantation Network (OPTN)
policy requires organ procurement organizations (OPOs) to
perform evaluations to determine whether there are
conditions that may influence donor acceptance (laboratory
testing, physical exam,medical/behavioral history, reviewof
donor’s medical records) and provide this information to
transplant centers considering organ offers (1). In addition,
policy requires OPOs and transplant centers to report any
unexpected potential donor-derived infection in a transplant
recipient to the OPTN within 24h of initial suspicion of
transmission. Reporting may involve one or more recipients
suspected to have, confirmed positive for, or deceased due
to disease (infectious or malignant) for which there is
substantial concern of donor origin. Conversely, reporting
may also be triggered by new donor information relevant to
acute patient care learned after recovery and/or transplant of
donor organs, with autopsy report or final culture results as
an example. Once a report is made, the OPTN Ad Hoc
Disease Transmission Advisory Committee (DTAC) confi-
dentially reviews all reports to determine if donor-derived
disease transmission occurred. The Committee then re-
views aggregate data on all reported cases to guide OPTN
policy development and educate the broader transplant
community regarding potential donor-derived events.
Effectively communicating relevant recipient and donor
information in real time to those involved in individual
transplant transmission events is challenging due to the
complexity of the communication networks among geo-
graphically diverse laboratories, OPOs, and recipient
transplant centers. Even with a web-based reporting
mechanism available through the OPTN Improving Patient
Safety portal, communication gaps may occur and in some
cases, have a significant impact on recipient morbidity and
mortality (7,8).
The purpose of this study was to determine if delays and
errors in communications occur in the reporting and
management of donor-derived infections and if communi-
cation gaps are associatedwith preventable adverse events
in transplant recipients. Based on our review of the DTAC
experience, we assessed the frequency and impact of
communication gaps.
Methods
We reviewed all potential donor-derived infection transmission events
reported to the OPTN DTAC from January 2008 to June 2010. We included
only infection events (IEs) classified as proven, probable or intervention
without documented transmission (IWDT) per standard DTAC case
classification (9). Donor-derived transmission classifications were defined
as follows: (1) proven: proven disease in the donor and at least one recipient;
(2) probable: disease in one or more recipients with suggestive data that the
donor was the source of the disease; (3) IWDT: no transmission occurred
due to the administration of antimicrobials to one or more of the recipients.
Case classification and recipient outcomes were based on follow-up at 45
days per OPTN policy.
Although OPTN policy requires information surrounding possible transmis-
sion events to be communicated within 24h (1), we defined a delay in
communication as >3 days. This time frame was chosen as the longest
reasonable time frame for reporting, acknowledging the difficult logistics that
are inherent in the reporting process, the relative newness of the reporting
system and our degree of certainty to accurately pinpoint when the
communication occurred. As each organ donor resulted in organ transplanta-
tion in one to five recipients and recognizing that not all recipients from a
common donor were of equal risk for the development of infection, a
separate analysis for adverse recipient events was performed among
reported transmission events that were classified as proven or probable.
Adverse recipient eventswere defined as the development of an unexpected
clinical infection, a more severe infection that resulted than otherwise would
have been expected had the communication delay or error not occurred, or
death. The association between adverse events and delay or error in
reporting was examined by comparing those recipients with delays or errors
to those in whom reporting occurred within the 72h time frame. Data were
analyzed using GraphPad Prism version 5 (GraphPad Software, San Diego,
CA) and SAS (version 9.3; SAS Institute, Cary, NC). Estimates of relative risk
were used to compare association between categorical variables as
appropriate. Additionally, the specific circumstance of the communication
gapwas determined in order to assesswhether therewas a specific situation
where communication breakdown was most likely to occur.
Results
We reviewed 66 IEs involving 196 transplant recipients
during a 2.5-year period. Ten IEs were excluded from
analysis. In three of these events, specific donor serologies
(human T-lymphotrophic virus, Toxoplasma and Trypano-
soma cruzii) were obtained preprocurement based on
known donor risk factors and resulted after transplantation.
In these cases, infection transmission was anticipated and
appropriate action was then taken preemptively in the
recipients after transplantation. For the remainder of
excluded IEs, no organism was identified (n¼ 1), serology
results were falsely negative and/or discordant (n¼ 5), or
test results were noninterpretable (n¼ 1).
As displayed in Table 1, of the 56 evaluable IEs (168
recipients), 38 IEs involving 120 transplant recipients were
without communication delays/errors (Figure 1). When
communication within the 72h window was effective and
prompt intervention (where available) was initiated, recipi-
ent infection was minimized or averted. In the 23 of 38 IEs
without communication delays/errors, intervention posi-
tively influenced case outcome for 72 of 120 transplant
recipients. For the remaining 15 IEs without communica-
tion delays/errors, the communication process had no
influence on the case outcome due to lack of availability of
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an effective treatment strategy (five IEs), prolonged
pathogen incubation time prohibiting timely identification
and intervention in recipients (six IEs), or deferral of
prophylaxis administration to the recipients by the trans-
plant center without adverse consequences (four IEs).
Conversely communication delays/errors were found in 18
IEs involving 48 transplant recipients. Twelve of the 18 IEs
with communication delays/errors (67%) were associated
with an adverse event in at least one recipient. These 12
events collectively involved 29 transplant recipients; 9/29
recipients (31%) had no adverse events associatedwith the
communication delay/error. However, the remaining 20/29
(69%) recipients experienced an adverse event, including
six recipient deaths.
Recognizing that not all transplant recipients receiving
organs from a common donor were at equal risk for the
development of an adverse event, a separate analysis was
performed among the recipients involved in potential donor-
derived IEs to determine if there was an association
between the incidence of proven or probable transmission
events and the occurrence of a communication gap. Among
the 56 evaluable IEs, there were 168 organ transplant
recipients. Of these, 56 recipients experienced a proven or
probable infection transmission event, whereas 112
recipients did not. Of the recipients that experienced a
proven or probable transmission, 26/56 (46.4%) were
subject to a communication gap. In comparison, 22/112
(19.6%) recipients without a proven or probable transmis-
sion were subject to a communication gap (Table 2). There
was a significant association between having a proven/
probable transmission or not, and the presence or absence
of a communication gap present (x21¼ 13.13, p¼ 0.0003).
The odds of a communication gap are 3.54 times higher
(95%CI [1.76, 7.16]) for those with a proven/probable
transmission than those without. Equivalently, recipients
with a proven or probable infection transmission event
were significantly more likely to have a communication gap
surrounding the transmission event than those recipients
whose exposure to a potential IE was without a communi-
cation gap. The relative risk of developing a proven or
probable infection transmission event was 2.36 (95%CI
[1.48–3.78]) for these recipients.
All pathogens involved in the 56 unexpected donor-derived
IEs are summarized in Table 3. For recipients with and
without communication gaps, IEs involving bacterial
Table 1: Summary of event and individual recipient outcomes for 56 proven, probable, and IWDT infection events reviewed by DTAC
January 2008–June 2010
IE % Recipients %
Communication delay
No 38 67.9 120 71.4
Yes 18 32.1 48 28.6
Total 56 100.0 168 100.0
IE Recipients
N % N %
No communication delay
Positive intervention 23 60.5 72 60.0
No influence 15 39.5 48 40.0
Total 38 100.0 120 100.0
Communication delay
At least one recipient with an adverse event 12 66.7 Adverse event 20 41.7
No adverse event 9 18.8
No adverse event 6 33.3 No adverse event 19 39.6
Total 18 100.0 Total 48 100.0
DTAC, Ad Hoc Disease Transmission Advisory Committee; IE, infection event; IWDT, intervention without documented transmission.
  66 Total IE 
56 Evaluable IE 
(168 R)
10 IE excluded
Communicaon Gaps Present
18 IE (48 R)
No Communicaon Gaps
38 IE (120 R) 
Figure 1: Potential donor-derived infection events (IE) and
coinciding numbers of recipients (R) reported to the Organ
Procurement and Transplantation Network Ad Hoc Disease
Transmission Advisory Committee, with and without
associated communication gaps.
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pathogens were the most common (61% and 47%,
respectively), followed by fungal pathogens (17% and
32%, respectively), viruses (17% and 13%, respectively)
and parasites (6%and 8%, respectively). Although thewide
variety of organisms found among the IEs precluded
systematic analysis due to small numbers of patients, the
proportion of antibiotic resistant bacterial pathogens
(defined as methicillin resistant Staphylococcus aureus,
vancomycin resistant Enterococcus, extended spectrum
betalactamase E. coli and other hospital-acquired Gram-
negative rod infections including Pseudomonas, Serratia,
Acinetobacter, Enterobacter) was higher in the group with
communication gaps (64% vs. 22% of bacterial IEs).
Recipients with donor-derived bacterial infections became
symptomatic in the range of 6–43 days after transplant. All
of the Cryptococcus transmissions occurred in the group
with communication gaps (n¼ 3 IEs), with a 1 month or
more delay by donor centers in performing donor autopsies
and communicating positive findings to the OPO in two of
these IEs. Four of the six recipient deaths were attributable
to donor-transmitted infections with antibiotic resistant
bacterial pathogens or Cryptococcus.
Upon closer review of the type of communication delays/
errors that occurred in all 18 IEswith communication errors/
delays, we identified that gaps occurred at several points in
the communication process and some IEs involved more
than one communication gap. Specifically, in five IEs, the
transplant center delayed contacting the OPO or the OPTN
with a suspected donor-derived infection (range 22–56
days). In four IEs, the laboratory failed to relay donor results
(including autopsy results) to the OPO and/or transplant
center. Other communication gaps included an OPO delay
in contacting the OPTN or transplant centers (three IEs),
clerical errors in the reporting donor viral serologies (three
IEs), and incomplete communication of test results by the
OPO to transplant centers (three IEs). Case details of three
of the aforementioned IEs have been previously published
(7,10,11).
Discussion
Communication between donor hospitals, OPOs and
transplant centers is a complex process, requiring the
ongoing exchange of information in a time-critical manner.
Our review of potential donor-derived infection transmis-
sion events reported to the OPTNDTAC demonstrates that
delays and errors in communication are frequent and occur
at multiple levels in the communication process. The
majority of communication gaps occurred within 2 months
of transplantation and involved bacterial pathogens. This is
likely the result ofOPTNpolicy requiring routine preprocure-
ment donor bacterial cultures and the ease of linking
subsequent recipient infections to these donor cultures,
rather than any characteristics inherent to bacterial
pathogens. These communication gaps contributed to
adverse outcomes among affected transplant recipients,
Table 2: Number of transplant recipients (%) with evaluable
potential donor-derived infection events reported to Organ
Procurement and Transplantation Network Ad Hoc Disease
Transmission Advisory Committee, comparing those recipients
with and without proven/probable transmissions and whether a
communications gap occurred
Communication gap
Total (%)Yes (%) No (%)
Proven/probable transmission
Yes (%) 26 (46.4) 30 (53.6) 56 (100.0)
No (%) 22 (19.6) 90 (80.4) 112 (100.0)
Total (%) 48 (28.6) 120 (71.4) 168 (100.0)
Table 3: Distribution of organisms involved in evaluable infection
events (IE) with and without associated communication gaps
Organism
type
Infection events
without communication
gaps (n¼ 38)
Infection events
with communication
gaps (n¼ 18)
Bacteria 18 total IEs (47%) 11 total IEs (61%)
Mycobacterium
tuberculosis (8)
Enterococcus sp.
Staphylococcus
aureus (MRSA)
Enterococcus (VRE)
Streptococcus
pneumoniae (2)
E. coli
Abiotrophia sp. ESBL E. coli
Enterococcus
gallinarium
Acinetobacter/
Enterobacter
E. coli Klebsiella sp.
Enterobacter sp. Pseudomonas sp. (2)
Pseudomonas sp. Serratia sp.
Serratia sp. Ehrlichia (2)
Nocardia
Viruses 5 total IEs (13%) 3 total IEs (17%)
West Nile virus (2) Cytomegalovirus
Parvovirus Hepatitis C virus
H1N1 influenza virus
Lymphocytic
choriomeningitis virus
Fungi 12 total IEs (32%) 3 total IEs (17%)
Candida albicans Cryptococcus
neoformans (3)
Candida glabrata
Aspergillus (2)
Coccidioides immitis (3)
Histoplasma capsulatum (2)
Blastomyces dermatitidis
Zygomyces
Parasites 3 total IEs (8%) 1 total IE (6%)
Strongyloides (2) Toxoplasma sp.
Balamuthia mandrillaris
ESBL, extended spectrum betalactamase; MRSA, methicillin resistant
Staphylococcus aureus; VRE, vancomycin resistant Enterococcus.
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in some cases even leading to potentially preventable
recipient deaths. Conversely, effective communicationwas
associatedwithminimized or averted infection in transplant
recipients through the implementation of preventive or
preemptive treatment strategies.
Based on observations such as these, improving commu-
nication at all levels in the transplant process has been an
area of focus in the transplant community, informed by
lessons learned by DTAC’s ongoing review of reports of
potential donor-derived disease transmissions. In 2011, the
OPTN implemented policy changes regarding communica-
tion, largely focusing on the procedures for OPOs and
transplant centers to report and share donor-related
information with relevant groups (1). This included policy
requiring the identification of specific individuals responsi-
ble for communication on a 24h daily basis at all centers and
OPOs. Further refinements of the process are currently
being explored by the OPTN as resources available for this
process vary tremendously at all levels and all institutions.
Obtaining results from diverse locations and communicat-
ing them in a timely manner is especially challenging given
the variable access to efficient communication systems. A
failuremode and effects analysis is currently underway as a
joint effort with representation from the OPO, Transplant
Administrators and Transplant Coordinators Committees.
The committee is tasked with identifying areas of
communication breakdown in this process in order to
improve posttransplant communication of new donor
information. Other organizations, including the Council of
State and Territorial Epidemiologists, Centers for Disease
Control and World Health Organization, are also involved in
improving these communication deficiencies in the context
of transplant-transmitted disease on a broader scope
(12,13). Educational efforts continue by all groups, targeting
transplant and nontransplant healthcare providers, to
increase awareness of potential donor-derived events,
utilize the existing reporting process, and understand the
channels of communication to obtain timely, clinically
relevant information for patient management. Our findings
also support future actions to require expedited donor
autopsies with reporting of findings to OPOs, as well as
safeguards to prevent clerical errors in the reporting of
donor serologies.
This study has several limitations, primarily related to the
existing OPTN reporting process. The data collection is
retrospective, and information available for reported IEs in
real time may be incomplete. Follow-up information on
these events is limited and testing recommendations
provided by DTAC necessary to prove/disprove donor
transmission are not always followed. As such, there is the
possibility of bias in data interpretation surrounding these
events. Recognition of IEs relies on the passive reporting
system through the OPTN. Although reporting of sus-
pected donor-derived transmission events is required by
OPTN policy (1), we believe that underreporting may occur,
due both to the failure of clinicians to recognize the
occurrence of this possibility or incomplete understanding
of the reporting requirements. The passive reporting
system also precludes determining the true incidence of
these transmission events due to lack of denominator
data. These limitations may result in an over- or under-
estimate of the number and severity of communication
gaps occurring within the organ procurement and trans-
plant process.
Despite these limitations, our study clearly highlights the
potential for communication gaps to lead to unexpected
and potentially preventable adverse events. Equally impor-
tantly, it highlights the potential benefits to timely
communication as a means to prevent or ameliorate the
impact of donor-derived transmissible disease, thereby
promoting the expansion of the donor pool by utilizingmore
donors with potentially treatable infections. Further re-
search to more fully understand the causal factors for
communication delays and errors is critically needed to
improve patient safety. Developing a comprehensive
understanding of how this communication process occurs
and the factors leading to inefficient transmission of critical
information will lead to developing steps to improve the
transplantation process.
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